Decoding Broadcom's Surge in Stock Price Today

After this afternoon's 4.3% surge to $1729.22 per share, Broadcom might just keep moving past its target price of $1756.64. With an average analyst rating of buy, and target prices from $1397.03 to $2002.4, the stock's next move is anyone's guess.

The stock has a very low short interest at 1.4%, and a short ratio of 1.76. The company's insiders own 2.03% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 79.7% of Broadcom's shares being owned by this investor type.

Institutions Invested in Broadcom

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 10% 44,651,273 $77,211,872,988
2024-03-31 Blackrock Inc. 8% 34,907,755 $60,363,187,078
2024-03-31 Capital World Investors 6% 25,949,836 $44,872,974,647
2024-03-31 Capital International Investors 5% 20,998,978 $36,311,852,121
2024-03-31 State Street Corporation 4% 18,198,644 $31,469,458,644
2024-03-31 Capital Research Global Investors 4% 17,434,197 $30,147,561,625
2024-03-31 Geode Capital Management, LLC 2% 9,524,609 $16,470,144,095
2024-03-31 Bank of America Corporation 2% 7,199,637 $12,449,756,082
2024-03-31 JP Morgan Chase & Company 1% 6,408,085 $11,080,988,555
2024-03-31 Morgan Stanley 1% 6,352,200 $10,984,351,097

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Broadcom.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.